See more : Huishang Bank Corporation Limited (3698.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Gujarat Ambuja Exports Limited (GAEL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Gujarat Ambuja Exports Limited, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- MegumaGold Corp. (NSAUF) Income Statement Analysis – Financial Results
- Saraswati Commercial (India) Limited (ZSARACOM.BO) Income Statement Analysis – Financial Results
- S. M. Gold Limited (SMGOLD.BO) Income Statement Analysis – Financial Results
- United Communications Partners Inc. (UCPA) Income Statement Analysis – Financial Results
- Mudrick Capital Acquisition Corporation II (MUDS) Income Statement Analysis – Financial Results
Gujarat Ambuja Exports Limited (GAEL.NS)
About Gujarat Ambuja Exports Limited
Gujarat Ambuja Exports Limited primarily engages in the agro processing activities in India and internationally. The company operates through Agro, Cotton, Maize, Power, and Other segments. It offers cotton yarns; wheat processing; and polyols, such as sorbitol, maltitol, and mannitol. The company also provides bakery shortenings, cotton seed refined oils, corn and groundnut refined oils, refined palm oil, soyabean refined oil, and vanaspati ghee; and soya flour/fakes/grits, liquid soya lecithin, and soya granules and nuggets. In addition, it feed ingredients, such as corn/maize gluten, rapeseed extraction, and soyabean meals, as well as cattle feed; and starch derivatives, including high maltose corn syrup, dextrose syrup, corn steep liquor, corn gluten meal, maize germ, malto dextrin powder, dextrins, dextrose anhydrous, dextrose monohydrate powder, maltose syrup, liquid glucose, maize and corn starch, and liquid sorbitol solution. Further, the company is involved in the power generation through windmills, biogas, thermal, and solar plants. It serves textile, paper, food, feed, cosmetics, pharmaceutical, and animal nutrition industries. The company was founded in 1986 and is based in Ahmedabad, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 49.27B | 49.09B | 46.70B | 47.05B | 38.17B | 40.21B | 33.29B | 33.31B | 27.36B | 25.31B | 30.92B | 30.16B | 21.22B | 19.61B | 14.30B | 16.21B | 18.45B | 14.12B | 13.16B | 11.18B |
Cost of Revenue | 36.70B | 35.47B | 32.91B | 35.55B | 30.66B | 30.95B | 25.99B | 26.23B | 21.56B | 19.83B | 24.74B | 24.86B | 18.44B | 15.38B | 82.00M | 863.00M | -555.20M | 11.34B | 10.85B | 9.20B |
Gross Profit | 12.57B | 13.62B | 13.79B | 11.50B | 7.51B | 9.26B | 7.30B | 7.08B | 5.80B | 5.48B | 6.18B | 5.29B | 2.78B | 4.23B | 14.22B | 15.34B | 19.01B | 2.78B | 2.31B | 1.98B |
Gross Profit Ratio | 25.52% | 27.75% | 29.53% | 24.45% | 19.67% | 23.03% | 21.93% | 21.24% | 21.20% | 21.66% | 19.99% | 17.55% | 13.11% | 21.59% | 99.43% | 94.68% | 103.01% | 19.70% | 17.56% | 17.71% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 127.30M | 111.30M | 78.30M | 70.00M | 52.70M | 50.10M | 40.40M | 40.90M | 38.20M | 0.00 | 26.10M | 22.70M | 210.90M | 1.55B | 108.00M | 107.70M | 193.90M | 105.30M | 81.30M | 64.50M |
Selling & Marketing | 2.12B | 2.13B | 1.95B | 1.97B | 939.00M | 1.52B | 1.17B | 861.90M | 741.00M | 0.00 | 886.10M | 673.70M | 690.20M | 671.10M | 482.70M | 666.60M | 949.60M | 748.10M | 663.60M | 572.00M |
SG&A | 2.25B | 2.25B | 2.03B | 2.04B | 991.70M | 1.57B | 1.21B | 902.80M | 779.20M | 805.80M | 1.72B | 1.43B | 901.10M | 2.22B | 590.70M | 774.30M | 1.14B | 853.40M | 744.90M | 636.50M |
Other Expenses | 10.05B | 740.10M | 16.40M | 288.50M | 28.90M | 57.80M | 15.10M | 4.13B | 3.73B | 4.44B | 4.70B | 3.71B | -4.30M | 759.60M | 12.72B | 14.00B | 16.61B | 1.14B | 1.03B | 975.60M |
Operating Expenses | 12.30B | 9.82B | 7.87B | 7.17B | 5.50B | 6.44B | 4.87B | 5.04B | 4.51B | 4.44B | 4.70B | 3.71B | 1.80B | 2.98B | 13.31B | 14.78B | 17.76B | 1.99B | 1.78B | 1.61B |
Cost & Expenses | 45.95B | 45.29B | 40.78B | 42.72B | 36.16B | 37.39B | 30.86B | 31.27B | 26.07B | 24.26B | 29.43B | 28.57B | 20.24B | 18.36B | 13.40B | 15.64B | 17.20B | 13.34B | 12.63B | 10.81B |
Interest Income | 574.80M | 527.80M | 268.50M | 90.20M | 32.80M | 25.10M | 22.30M | 20.80M | 27.20M | 27.50M | 43.50M | 70.30M | 29.30M | 0.00 | 31.80M | 61.40M | 28.70M | -13.00M | 48.20M | 0.00 |
Interest Expense | 183.80M | 132.60M | 22.20M | 30.80M | 46.50M | 125.40M | 135.80M | 179.40M | 54.40M | 124.40M | 206.50M | 217.30M | 209.40M | 126.20M | 52.80M | 103.60M | 181.30M | 69.10M | 51.90M | 0.00 |
Depreciation & Amortization | 1.21B | 946.60M | 973.30M | 1.03B | 1.01B | 956.50M | 762.90M | 714.20M | 651.30M | 609.70M | 474.10M | 366.80M | 298.60M | 292.30M | 279.10M | 363.60M | 314.60M | 251.00M | 237.70M | 235.80M |
EBITDA | 5.87B | 5.49B | 7.41B | 5.61B | 2.91B | 3.84B | 3.26B | 2.97B | 1.98B | 1.74B | 2.05B | 1.97B | 1.07B | 1.55B | 1.18B | 928.60M | 1.56B | 1.04B | 772.60M | 603.70M |
EBITDA Ratio | 11.92% | 11.18% | 15.58% | 11.71% | 7.70% | 9.44% | 9.65% | 8.35% | 6.95% | 6.60% | 6.29% | 6.46% | 6.00% | 7.87% | 8.28% | 5.73% | 8.48% | 7.35% | 5.87% | 5.40% |
Operating Income | 3.21B | 3.86B | 5.92B | 4.33B | 1.93B | 2.82B | 2.43B | 2.04B | 1.29B | 1.05B | 1.48B | 1.59B | 979.70M | 1.25B | 904.40M | 565.00M | 1.25B | 787.70M | 534.90M | 367.80M |
Operating Income Ratio | 6.52% | 7.85% | 12.67% | 9.21% | 5.06% | 7.01% | 7.31% | 6.12% | 4.73% | 4.14% | 4.80% | 5.26% | 4.62% | 6.38% | 6.32% | 3.49% | 6.77% | 5.58% | 4.06% | 3.29% |
Total Other Income/Expenses | 1.26B | 555.60M | 462.40M | 191.60M | -117.60M | -124.20M | -111.40M | -19.60M | -67.90M | -122.60M | -116.80M | -35.70M | -160.10M | -135.00M | -88.40M | -110.50M | -152.50M | -82.10M | -75.10M | -61.40M |
Income Before Tax | 4.48B | 4.41B | 6.38B | 4.52B | 1.81B | 2.70B | 2.32B | 1.99B | 1.23B | 976.80M | 1.37B | 1.45B | 607.10M | 1.14B | 816.00M | 454.50M | 1.10B | 698.50M | 459.80M | 306.40M |
Income Before Tax Ratio | 9.08% | 8.99% | 13.66% | 9.61% | 4.75% | 6.70% | 6.97% | 5.99% | 4.49% | 3.86% | 4.42% | 4.81% | 2.86% | 5.81% | 5.71% | 2.80% | 5.95% | 4.95% | 3.49% | 2.74% |
Income Tax Expense | 1.02B | 1.11B | 1.63B | 1.14B | 355.10M | 714.00M | 522.80M | 408.20M | 191.20M | 135.90M | 253.10M | 322.90M | 108.00M | 253.80M | 300.50M | 213.00M | 382.60M | 230.70M | 153.10M | 40.20M |
Net Income | 3.46B | 3.30B | 4.75B | 3.38B | 1.46B | 1.98B | 1.80B | 1.59B | 1.04B | 840.90M | 1.11B | 1.13B | 499.10M | 931.90M | 607.20M | 242.50M | 714.40M | 467.80M | 306.70M | 266.20M |
Net Income Ratio | 7.02% | 6.72% | 10.18% | 7.18% | 3.82% | 4.93% | 5.40% | 4.76% | 3.79% | 3.32% | 3.60% | 3.74% | 2.35% | 4.75% | 4.25% | 1.50% | 3.87% | 3.31% | 2.33% | 2.38% |
EPS | 7.54 | 7.20 | 10.37 | 7.37 | 3.18 | 8.64 | 7.84 | 5.75 | 3.63 | 3.04 | 3.03 | 4.08 | 1.81 | 3.35 | 2.19 | 0.88 | 2.58 | 1.68 | 1.10 | 0.96 |
EPS Diluted | 7.54 | 7.20 | 10.37 | 7.37 | 3.18 | 8.64 | 7.84 | 5.75 | 3.63 | 3.04 | 3.03 | 4.08 | 1.81 | 3.35 | 2.19 | 0.88 | 2.58 | 1.68 | 1.10 | 0.96 |
Weighted Avg Shares Out | 458.70M | 458.60M | 458.60M | 458.60M | 458.80M | 229.40M | 229.40M | 275.80M | 276.70M | 276.70M | 276.70M | 276.70M | 276.70M | 276.70M | 276.70M | 276.70M | 277.63M | 278.64M | 278.64M | 278.64M |
Weighted Avg Shares Out (Dil) | 458.70M | 458.60M | 458.60M | 458.60M | 458.80M | 229.40M | 229.40M | 275.80M | 276.80M | 276.70M | 276.70M | 276.70M | 276.70M | 276.70M | 276.70M | 276.70M | 277.63M | 278.64M | 278.64M | 278.64M |
Source: https://incomestatements.info
Category: Stock Reports